PHARMACYTE BIOTECH, INC. Preferred Stock, Value, Issued
PHARMACYTE BIOTECH, INC. (PMCB) had Preferred Stock, Value, Issued of $0 as of 2026-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2026-07-29
- 2026-04-30: Preferred Stock, Value, Issued $0.00.
- 2025-04-30: Preferred Stock, Value, Issued $0.00.
- 2025-01-31: Preferred Stock, Value, Issued $0.00.
- 2024-10-31: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2026-04-30 | $0.00 10-K · filed 2026-07-29 |
| 2025-04-30 | $0.00 10-K · filed 2026-07-29 |
| 2025-01-31 | $0.00 10-Q · filed 2025-03-17 |
| 2024-10-31 | $0.00 10-Q · filed 2024-12-13 |
| 2024-07-31 | $0.00 10-Q · filed 2024-09-17 |
| 2024-04-30 | $0.00 10-K · filed 2025-08-11 |
| 2024-01-31 | $0.00 10-Q · filed 2024-03-18 |
| 2023-10-31 | $0.00 10-Q · filed 2023-12-15 |
| 2023-07-31 | $20.03M 10-Q · filed 2024-09-17 |
| 2023-04-30 | $0.00 10-K · filed 2024-08-13 |
| 2020-01-31 | $0.00 10-Q · filed 2020-03-13 |
| 2019-04-30 | $0.00 10-Q · filed 2020-03-13 |
| 2016-01-31 | $0.00 10-Q · filed 2016-03-08 |
| 2015-10-31 | $0.00 10-Q/A · filed 2016-01-19 |
| 2015-07-31 | $0.00 10-Q/A · filed 2016-01-19 |
| 2015-04-30 | $0.00 10-Q · filed 2016-03-08 |
| 2015-01-31 | $0.00 10-Q · filed 2015-03-13 |
| 2014-10-31 | $0.00 10-Q · filed 2014-12-15 |
| 2014-07-31 | $0.00 10-Q · filed 2014-09-15 |
| 2014-04-30 | $0.00 10-K/A · filed 2016-01-19 |
| 2014-01-31 | $0.00 10-Q · filed 2014-03-17 |
| 2013-10-31 | $0.00 10-Q · filed 2013-12-16 |
| 2013-07-31 | $500.00K 10-Q · filed 2013-09-16 |
| 2013-04-30 | $580.00K 10-K · filed 2014-08-04 |
| 2013-01-31 | $580.00K 10-Q · filed 2013-03-26 |
| 2012-10-31 | $580.00K 10-Q · filed 2012-12-26 |
| 2012-07-31 | $580.00K 10-Q · filed 2012-09-19 |
| 2012-04-30 | $580.00K 10-K · filed 2013-07-29 |
| 2011-03-01 | $80.00K 10-Q · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |